Pharmalittle: We're reading about Medicare drug negotiations, a Novartis malaria drug, and more
Ed Silverman • July 8, 2025

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug price negotiations

Health care experts are warning that costs for insurance will likely rise again in 2025.One trend that may be contributing to higher insurance costs is the growing market concentration among fewer insurance companies.We recently looked at changes in private health insurance market concentration. We also compared costs under two types of private health plans—employer-sponsored plans and individual plans offered on the Healthcare.gov Marketplace.Today’s WatchBlog post looks at what we found and reported in two new reports about these trends.